Aimwell Bio
Tracked across 3 events · 19 articles · First seen Apr 22, 2026 · Last active Aug 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Aimwell Bio, a healthcare intelligence platform company, announced the executed assignment of the Trustr intellectual property portfolio, a patented behavioral engagement system designed to measure real-world patient behavior and use data-driven interventions to support medication…
Impact: Aimwell Bio is the acquirer of the Trustr IP portfolio, which strengthens its platform and expands its advisory network. This event is central to its growth strategy and could improve its market position.
Aug 17, 2026 · 6 articles
Tech
Impact: Aimwell Bio, a subsidiary of Aimwell Partners, developed and published the Adversarial Validation Standard, v1, which is its operating methodology for validating AI-generated intelligence in the biopharmaceutical industry. This enhances its credibility and market offering.
Jul 01, 2026 · 6 articles
Business
Impact: Aimwell Bio is the platform offering free Observer access and publishing its validation standard, enhancing transparency and user trust.
Jul 22, 2026 · 7 articles
100
Aimwell Bio acquiredAimwellBio Acquires Trustr...
ERGEN INTELLIGENCE
Track Aimwell Bio live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard